60 Degrees Pharmaceuticals Inc. (SXTP)
NASDAQ · Healthcare
60 Degrees Pharmaceuticals Inc. Revenue 2020–2025
60 Degrees Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- 60 Degrees Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 162092, a 0.89% decrease year-over-year.
- 60 Degrees Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 1.0 M.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2025 was 1.0 M, a 65.49% increase from 2024.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2024 was 607574, a 139.61% increase from 2023.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2023 was 253573, a 13.60% increase from 2022.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2022 was 223208.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
60 Degrees Pharmaceuticals Inc. Revenue — FAQ
60 Degrees Pharmaceuticals Inc. (SXTP) revenue over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is 60 Degrees Pharmaceuticals Inc.'s revenue?
60 Degrees Pharmaceuticals Inc. (SXTP) reported revenue of $1M for fiscal 2025.
Where can I see SXTP's revenue history?
The chart and table above show 60 Degrees Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.